Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1841-1850 of 2905 for cancer

Edit search filters
  1. Study Of Safety And Efficacy Of Dapagliflozin + Metformin XR Versus Metformin XR In Participants With HR+, HER2-, Advanced Breast Cancer While On Treatment With Alpelisib And Fulvestrant

    Jacksonville, FL, Rochester, MN

  2. Safety And Efficacy Of Bb2121 (Ide-cel) Combinations In Multiple Myeloma

    Jacksonville, FL

  3. A Clinical Study Of MK-1084 With Targeted Therapy And Chemotherapy In People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study To Evaluate Clinical Transplant-Related Long-term Outcomes Of Alternative Donor Allogeneic Transplantation

    Rochester, MN

  5. A Study To Evaluate The Feasibility Of Memantine In Reducing Cognitive Impairment In Pediatric Patients After Radiation Therapy For Central Nervous System Tumors

    Rochester, MN

  6. A Phase 2 Study Of Anti-PD-L1 Antibody Atezolizumab In Alveolar Soft Part Sarcoma

    Rochester, MN

  7. TAS-102 And Radiation Therapy In Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, Or Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. Cetuximab With Or Without Tivantinib In Treating Patients With Head And Neck Cancer That Is Recurrent, Metastatic, Or Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Study Of Pembrolizumab (MK-3475) Compared To Platinum-Based Chemotherapies In Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)

    Rochester, MN

  10. Targeted Treatment For Advanced Non-Small Cell Lung Cancer That Has Increased Copies Of The MET Gene (An Expanded Lung-MAP Treatment Trial)

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer